Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
暂无分享,去创建一个
H. Bergmeister | C. Pirker | W. Berger | S. Chin | C. Caldas | W. Mikulits | C. Cerni | A. Brachner | M. Micksche | M. Wieser | M. Mikula | U. Setinek | S. Sasgary | Chantal Rodgarkia
[1] M. Cerone,et al. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT , 2005, Oncogene.
[2] U. Pastorino,et al. Lack of Telomerase Activity in Lung Carcinoids Is Dependent on Human Telomerase Reverse Transcriptase Transcription and Alternative Splicing and Is Associated with Long Telomeres , 2005, Clinical Cancer Research.
[3] J. Barrett,et al. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. , 2005, Cancer research.
[4] L. Guarente,et al. A novel telomere structure in a human alternative lengthening of telomeres cell line. , 2005, Cancer research.
[5] R. Reddel,et al. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. , 2005, Cancer research.
[6] M. Ladanyi,et al. Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas , 2004, Genes, chromosomes & cancer.
[7] E. Montgomery,et al. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically. , 2004, The American journal of pathology.
[8] E. Brambilla,et al. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours , 2004, British Journal of Cancer.
[9] K. Kikuchi,et al. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma , 2003, Cancer.
[10] W. Berger,et al. Detection and quantification of transcripts for the catalytic subunit TERT and the RNA component of telomerase in rat tissue. , 2003, Analytical biochemistry.
[11] James M. Roberts,et al. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation , 2003, Nature Cell Biology.
[12] M. Ladanyi,et al. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. , 2003, Cancer research.
[13] R. Newbold. The significance of telomerase activation and cellular immortalization in human cancer. , 2002, Mutagenesis.
[14] G. Hannon,et al. Transformation of normal human cells in the absence of telomerase activation. , 2002, Cancer cell.
[15] Li Mao,et al. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] Robert A. Weinberg,et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Marchetti,et al. Prediction of Survival in Stage I Lung Carcinoma Patients by Telomerase Function Evaluation , 2002, Laboratory Investigation.
[18] R. Schulte‐Hermann,et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.
[19] R. Reddel,et al. Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.
[20] M. Henriksson,et al. Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1 , 2002, Oncogene.
[21] T. Kameya,et al. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. , 2001, Lung cancer.
[22] A. Jauch,et al. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas , 2001, Oncogene.
[23] R. Reddel,et al. Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells , 2001, Molecular and Cellular Biology.
[24] M. Blasco,et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.
[25] Carol W. Greider,et al. Two Survivor Pathways That Allow Growth in the Absence of Telomerase Are Generated by Distinct Telomere Recombination Events , 2001, Molecular and Cellular Biology.
[26] R. Reddel,et al. Telomere maintenance by recombination in human cells , 2000, Nature Genetics.
[27] R. Reddel. The role of senescence and immortalization in carcinogenesis. , 2000, Carcinogenesis.
[28] T. Mohr,et al. Evidence for a role of FGF‐2 and FGF receptors in the proliferation of non‐small cell lung cancer cells , 1999, International journal of cancer.
[29] R. Reddel,et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.
[30] Robert A. Weinberg,et al. Creation of human tumour cells with defined genetic elements , 1999, Nature.
[31] E. Blackburn,et al. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Regev,et al. Telomeric repeats on small polydisperse circular DNA (spcDNA) and genomic instability , 1998, Oncogene.
[33] V. Lundblad,et al. The telomerase reverse transcriptase: components and regulation. , 1998, Genes & development.
[34] C. Harley,et al. Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.
[35] M. Oshimura,et al. A repressor function for telomerase activity in telomerase‐negative immortal cells , 1998, Molecular carcinogenesis.
[36] T. Slaga,et al. Telomerase and cell proliferation in mouse skin papillomas , 1997, Molecular carcinogenesis.
[37] E. Dmitrovsky,et al. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. , 1997, Journal of the National Cancer Institute.
[38] D. Bowtell,et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.
[39] R. Reddel,et al. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.
[40] W. Berger,et al. Expression of the multidrug resistance‐associated protein (MRP) and chemoresistance of human non‐small‐cell lung cancer cells , 1997 .
[41] R. Weinberg,et al. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.
[42] J. Shay,et al. A survey of telomerase activity in human cancer. , 1997, European journal of cancer.
[43] B. Gallie,et al. Development of retinoblastoma in the absence of telomerase activity. , 1996, Journal of the National Cancer Institute.
[44] S. Lavi,et al. Induction of circles of heterogeneous sizes in carcinogen-treated cells: two-dimensional gel analysis of circular DNA molecules , 1996, Molecular and cellular biology.
[45] H. Tanke,et al. Heterogeneity in telomere length of human chromosomes. , 1996, Human molecular genetics.
[46] R. Reddel,et al. Telomere elongation in immortal human cells without detectable telomerase activity. , 1995, The EMBO journal.
[47] C. Seelos,et al. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins. , 1995, Oncogene.
[48] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[49] C B Harley,et al. Telomere length predicts replicative capacity of human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Shay,et al. The two-stage mechanism controlling cellular senescence and immortalization , 1992, Experimental Gerontology.
[51] C. Harley,et al. Telomeres shorten during ageing of human fibroblasts , 1990, Nature.
[52] N. Wald,et al. Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003 .
[53] J. Shay,et al. Telomerase in cancer and aging. , 2002, Critical reviews in oncology/hematology.
[54] M. White,et al. Absence of cancer–associated changes in human fibroblasts immortalized with telomerase , 1999, Nature Genetics.
[55] Gregg B. Morin,et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.
[56] S. Bacchetti. Telomere maintenance in tumour cells. , 1996, Cancer surveys.